Literature DB >> 7651386

p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53.

T H Shin1, A J Paterson, J E Kudlow.   

Abstract

Physical and chemical agents can damage the genome. Part of the protective response to this damage is the increased expression of p53. p53, a transcription factor, controls the expression of genes, leading to cell cycle arrest and apoptosis. Another protective mechanism is the proliferative response required to replace the damaged cells. This proliferation is likely to be signaled by growth factors. In this communication, we show that the transforming growth factor alpha (TGF-alpha) gene is a direct target for p53-mediated transcriptional activation. In a stable cell line containing an inducible p53 construct, p53 induction leads to a threefold accumulation of the native TGF-alpha mRNA. IN cotransfection assays using a TGF-alpha promoter reporter construct, we show that expression of wild-type but not mutant p53 increases transcriptional activity of the TGF-alpha promoter by approximately 2.5-fold. In vitro, wild-type p53 binds to a consensus binding site found in the proximal portion of the promoter, and this sequence is necessary for the p53 transcriptional response. Furthermore, this element confers p53 induction to the otherwise nonresponsive adenovirus major late promoter. In addition to these results, we found that the TGF-alpha promoter contains a nonconsensus but functional TATA box-binding protein-binding site approximately 30 bp upstream of the transcription start site. Although p53 can repress transcription from promoters containing a TATA box, the nonconsensus TGF-alpha TATA motif is resistant to this effect. On the basis of these results, we propose that p53 may play a dual role, which includes both the elimination of irreparably genetically damage cells and the proliferative response necessary for their replacement, in the response to physical-chemical damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651386      PMCID: PMC230712          DOI: 10.1128/MCB.15.9.4694

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  The human transforming growth factor alpha promoter directs transcription initiation from a single site in the absence of a TATA sequence.

Authors:  E B Jakobovits; U Schlokat; J L Vannice; R Derynck; A D Levinson
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

2.  Functional domains and upstream activation properties of cloned human TATA binding protein.

Authors:  M G Peterson; N Tanese; B F Pugh; R Tjian
Journal:  Science       Date:  1990-06-29       Impact factor: 47.728

3.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

4.  Identification and characterization of the human transforming growth factor-alpha initiator.

Authors:  T H Shin; J E Kudlow
Journal:  Mol Endocrinol       Date:  1994-06

5.  Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease.

Authors:  R G Korneluk; D J Mahuran; K Neote; M H Klavins; B F O'Dowd; M Tropak; H F Willard; M J Anderson; J A Lowden; R A Gravel
Journal:  J Biol Chem       Date:  1986-06-25       Impact factor: 5.157

6.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

7.  Yeast TATA-binding protein TFIID binds to TATA elements with both consensus and nonconsensus DNA sequences.

Authors:  S Hahn; S Buratowski; P A Sharp; L Guarente
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  UVR induction of TGF alpha: a possible autocrine mechanism for the epidermal melanocytic response and for promotion of epidermal carcinogenesis.

Authors:  K A Ellem; M Cullinan; K C Baumann; A Dunstan
Journal:  Carcinogenesis       Date:  1988-05       Impact factor: 4.944

9.  Characterization of the rat transforming growth factor alpha gene and identification of promoter sequences.

Authors:  A J Blasband; K T Rogers; X R Chen; J C Azizkhan; D C Lee
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

10.  Transforming growth factor-alpha in the mammalian brain. Immunohistochemical detection in neurons and characterization of its mRNA.

Authors:  J E Kudlow; A W Leung; M S Kobrin; A J Paterson; S L Asa
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

View more
  20 in total

1.  Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators.

Authors:  Jamie M Hearnes; Deborah J Mays; Kristy L Schavolt; Luojia Tang; Xin Jiang; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

2.  Restoration of endogenous wild-type p53 activity in a glioblastoma cell line with intrinsic temperature-sensitive p53 induces growth arrest but not apoptosis.

Authors:  J Ikeda; M Tada; N Ishii; H Saya; K Tsuchiya; K Okaichi; K Mishima; Y Sawamura; G Fulci; T J Liu; E G Van Meir
Journal:  Int J Cancer       Date:  2001-10-01       Impact factor: 7.396

3.  Wild-type but not mutant p53 activates the hepatocyte growth factor/scatter factor promoter.

Authors:  A M Metcalfe; R M Dixon; G K Radda
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

4.  Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.

Authors:  J H Ludes-Meyers; M A Subler; C V Shivakumar; R M Munoz; P Jiang; J E Bigger; D R Brown; S P Deb; S Deb
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

5.  Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors.

Authors:  M Schiebe; P Ohneseit; W Hoffmann; R Meyermann; H P Rodemann; M Bamberg
Journal:  J Neurooncol       Date:  2000-09       Impact factor: 4.130

6.  Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates.

Authors:  Tomás R Guilarte; Neal C Burton; Tatyana Verina; Vinaykumar V Prabhu; Kevin G Becker; Tore Syversen; Jay S Schneider
Journal:  J Neurochem       Date:  2008-02-13       Impact factor: 5.372

7.  Expression patterns of cytokine, growth factor and cell cycle-related genes after partial hepatectomy in rats with thioacetamide-induced cirrhosis.

Authors:  Shu Yang; Chon Kar Leow; Theresa May Chin Tan
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

8.  Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells.

Authors:  Stephanie Harkey Shirley; Joyce E Rundhaug; Jie Tian; Noirin Cullinan-Ammann; Isabel Lambertz; Claudio J Conti; Robin Fuchs-Young
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

9.  Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors.

Authors:  D R Germolec; J Spalding; H S Yu; G S Chen; P P Simeonova; M C Humble; A Bruccoleri; G A Boorman; J F Foley; T Yoshida; M I Luster
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

10.  Transcriptional Regulation of Human Transforming Growth Factor-α in Astrocytes.

Authors:  Pratap Karki; James Johnson; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  Mol Neurobiol       Date:  2016-01-21       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.